This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pain Animal Model Development Service
Introduction
Empowering your analgesic discovery with precision and reliability. Are you facing bottlenecks in your R&D pipeline or struggling with the complexity of preclinical pain characterization? At BioVenic, we provide a sophisticated suite of pain animal model development services. By integrating diverse induction techniques-including surgical, chemical, and genetic methods-with multi-dimensional validation and bio-sampling, BioVenic delivers high-quality data that bridges the gap between basic research and non-GLP preclinical studies. Our bespoke solutions are designed to simplify your experimental workflow and provide the robust evidence needed to advance your lead compounds.
BioVenic Pain Animal Model Development Services
Pain Animal Model Development
BioVenic specializes in the meticulous construction of a wide array of pain models, ranging from standard acute nociception to complex chronic neuropathic conditions. Beyond traditional models, we offer customized development tailored to your specific research objectives. Our team optimizes variables such as animal strain, sex, and induction intensity. BioVenic's advantage lies in our high success rates and the exceptional reproducibility of our models, ensuring that your data stands up to rigorous scientific scrutiny.
Pain Animal Model Validation and Characterization Services
To ensure the translational value of every model, we provide comprehensive validation services. We employ gold-standard behavioral assays to confirm the successful induction of pain phenotypes. Common validation methods include von Frey filaments for mechanical allodynia, Hot Plate/Tail Flick tests for thermal hyperalgesia, and Incapacitance Testing for weight-bearing asymmetry. By documenting clear baseline shifts and post-induction sensitivity, we provide a "birth certificate" for every model, guaranteeing that the physiological state is appropriate for your downstream testing.
Biological Sampling Services
Precision in pain research often requires analysis beyond behavioral observation. BioVenic offer expert sampling of tissues and fluids to support your molecular inquiries. BioVenic's scientists are trained in rapid micro-dissection and cryopreservation techniques to maintain the integrity of delicate RNA, protein, and metabolite signatures.
Downstream Experimental Research on Pain Animal Models
Leveraging our established models, we conduct a variety of downstream studies to evaluate compound efficacy and mechanism of action. BioVenic's research services include Dose-Response Profiling for analgesic candidates, Pharmacokinetic/Pharmacodynamic (PK/PD) Correlation in pain states, and Histopathological Analysis of nerve morphology. We also offer molecular assays such as Western Blotting and ELISA to track changes in inflammatory mediators and ion channel expression.
Explore BioVenic's investigative modalities:
- Animal Behavioral Analysis
- Animal Histopathology Service
- Preclinical Animal Pharmacodynamics (PD) Study
- Preclinical Animal Pharmacokinetics (PK) Study
- Animal Cell Biology Service
- Animal Imaging Service
BioVenic's animal model development services also include:
- Genome-edited Animal Model Development
- Chemically-induced Animal Model Development
- Surgically-induced Animal Model Development
Development Workflow for a Pain Animal Model
Pain Animal Models and Application Fields
Table. 1 Common Pain Animal Models and Application Fields
| Model Category | Representative Models | Induction Method | Common Animals | Application & Research Fields |
|---|---|---|---|---|
| Neuropathic Pain (Peripheral) | SNL, SNI, CCI, PSL, CCD | Surgical ligation, constriction, or partial injury of the sciatic or spinal nerves (e.g., L5/L6). | SD Rats, C57BL/6 Mice | Chronic pain mechanisms, nerve injury recovery, and screening for neuropathic analgesics. |
| Inflammatory Pain | CFA, Formalin, Carrageenan, LPS | Subcutaneous or intraplantar injection of irritants (Complete Freund's Adjuvant, Formalin, etc.). | SD Rats, C57BL/6, ICR Mice | NSAIDs screening, inflammatory pathway research, and immune-mediated pain studies. |
| Acute / Nociceptive Pain | Hot Plate, Tail Flick, Acetic Acid Writhing | Thermal stimulus (heat/cold), electrical stimulation, or IP injection of chemical irritants (Acetic Acid). | Mice (ICR/C57), SD Rats | Basic pain threshold testing, screening of central (opioid) and peripheral analgesics. |
| Disease-Specific Pain | Migraine, Diabetic (DNP), Cancer Pain, OA | Chemical triggers (NTG), STZ injection for diabetes, tumor cell inoculation, or MIA for osteoarthritis. | SD Rats, C57BL/6 Mice | Targeted drug development for clinical conditions (e.g., migraine, oncology, metabolic diseases). |
| Central Neuropathic Pain | Spinal Cord Injury (SCI) | Weight-drop (contusion), photochemical injury, or excitatory spinal cord injury. | SD Rats | Central nervous system (CNS) trauma research and chronic spinal pain treatments. |
| Visceral Pain | Acetic acid-induced writhing, Colorectal Distension (CRD) | IP injection of acetic acid or balloon dilation/stretching of internal organs. | C57BL/6 Mice, SD Rats | IBS research, gastrointestinal pain, and visceral hyperalgesia studies. |
| Post-operative Pain | Brennan Model (Incision) | Longitudinal incision of the skin and fascia of the hind paw under anesthesia. | SD Rats, C57BL/6 Mice | Surgical recovery pain, clinical anesthesia research, and post-op analgesic efficacy. |
| Toxic/Drug-Induced Pain | CIPN (Chemotherapy-induced) | Systemic administration of chemotherapy agents like Paclitaxel or Vincristine. | SD Rats, C57BL/6 Mice | Side-effect management in oncology and neuroprotection studies. |
Advantages of BioVenic Pain Animal Model Development Service
Diverse Methodologies
BioVenic's platform integrates genetic, chemical, dietary, and surgical induction methods. We combine these approaches to build complex models that mimic the multi-factorial nature of chronic pain.
Advanced Detection Capabilities
We feature a robust validation platform. Beyond behavioral thresholds, we offer biochemical and pathological detection, including Cytokine Profiling (IL-1β, TNF-α) and Immunohistochemistry (IHC) for markers.
One-Stop Integrated Service
From initial model induction to complex downstream molecular analysis, we provide a seamless "one-stop" experience, eliminating the need for multiple vendors and ensuring data continuity.
Case Study: Chronic Inflammatory Pain & Metabolic-Analgesic Evaluation
BioVenic provides a high-fidelity CFA-induced inflammatory pain model, optimized for evaluating the long-term efficacy of novel analgesic candidates. We ensure rigorous validation of the pain state through standardized mechanical allodynia assessments using Von Frey filaments, alongside precise quantification of localized inflammation via paw edema measurements. This service is specifically designed to support the discovery of novel molecular targets, providing detailed data on the modulation of mechanical withdrawal thresholds and the suppression of systemic pro-inflammatory cytokines (IL-1beta, TNF-alpha). Furthermore, we offer advanced mechanistic profiling to investigate the metabolic drivers of pain. By combining consistent sensory testing with deep immune-metabolic analysis, we deliver a robust framework for validating next-generation therapeutics for chronic pain management.
Fig. 1 Effects of HSPA1A on paw PWTs in CFA-induced inflammatory pain mouse models1
FAQs
Can you perform studies on both male and female animals?
Yes. Recognizing the significant sexual dimorphism in pain processing, we offer studies in both sexes to help you identify gender-specific efficacy or safety profiles.
Do you provide live animals to our facility after model induction?
No, we are a service-based CRO. We perform the model development and all subsequent experimental procedures within our specialized facilities to ensure environmental consistency and data quality.
Is your facility GLP-compliant?
We specialize in high-quality non-GLP preclinical research, perfect for lead optimization, proof-of-concept studies, and internal R&D decision-making.
Contact Us
From elucidating fundamental pain mechanisms to evaluating the efficacy of your lead compounds, BioVenic is your trusted partner in pain research. Our senior scientists are ready to transform your research objectives into reproducible, high-quality data through our expert model development and downstream analysis services. Streamline your non-GLP preclinical trials today with a team that understands the nuances of sensory biology. Contact us today to request a quote and schedule a technical consultation with our scientific team.
Reference
- Zhang, Wenjie et al. "HSPA1A Can Alleviate CFA-Induced Inflammatory Pain by Modulating Macrophages." International journal of molecular sciences vol. 26,19 9591. 1 Oct. 2025. https://doi.org/10.3390/ijms26199591. Distributed under Open Access license CC BY 4.0. Without Modification.